However, the activation of HIF1α by ROS in sublethally damaged tumor cells closer to the vessels allows the expression of HIF1α-driven genes that contribute to their survival and growth thereby increasing their commitment to malignancy. The gene discussed is HIF1A; the disease is neoplasm.